Division of Rheumatology:
Research and Laboratories

Through clinical research we are helping discover which medications might be best for patients with many diseases. We are also investigating new therapies which may be released in the future. Many of our disease are related to problems with immune system, and many of the new therapies are directed towards helping rectify these subtle abnormalities. Our division is particularly interested in these types of problem and we are relentless in the search for the best treatment for each patient.

Current research initiatives include:

  • A Randomized, Double-Blind, Parallel Group, International Study to Evaluate the Safety and Efficacy of Ocrelizumab Compared to Placebo in Patients with Active Rheumatoid Arthritis Continuing Methotrexate-Treatment Phase. Funded by Genentech Incorporated.

  • A Long Term Study of the Safety of Rituxan in Patients with Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE) Funded by Genentech Incorporated.


Learn more about the Division of Rheumatology.


1-800-222-5864
Refer a Patient

Connect with Us Online


Become our fan on facebook!   Subscribe to our YouTube channel!   Follow us on Twitter!   Subscribe to our News RSS feed.  Learn about CarePages, an online support community.

eNewsletters and More

Faculty by Research


The discoveries made in the laboratories at National Jewish Health have a profound impact on the understanding and treatment of human disease.

Browse our A-Z directory of Faculty by Area of Research.